Bayer’s BAY2927088 to face competition in EGFR-mutant but limited competition in HER2-exon 20 mutant NSCLC market in China: GlobalData Read more
Vertex could solidify dominance in cystic fibrosis market with vanza triple approval: GlobalData Read more
Takeda’s phase 2b study of Mezagitamab shows potential to transform treatment of primary immune Thrombocytopenia Read more